Zelira Therapeutics’ cannabis trial meets goals for insomnia

The company’s cannabis formulation ZTL-101 was assessed for its efficacy to treat insomnia. Credit: 7raysmarketing from Pixabay.



  • Zelira Therapeutics’ cannabis trial meets goals for insomnia